MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5606/tgkdc.dergisi.2023.24329

Медицинская библиотека · Turk gogus kalp damar cerrahisi dergisi · 2023

Survival of pleurectomy-decortication and hyperthermic chemotherapy in mesothelioma.

Ergönül Ayşe Gül, Aydın Sercan, Kahraman Aydın Seda, Akçam Tevfik İlker, Özdil Ali, Turhan Kutsal, Çakan Alpaslan, Çağırıcı Ufuk

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

This study aims to evaluate overall survival, diseasefree survival, and prognostic factors in patients undergoing pleurectomy-decortication and hyperthermic intrathoracic chemotherapy with the diagnosis of malignant pleural mesothelioma.

METHODS

Between January 2020 and November 2021, a total of 53 patients (27 males, 26 females; mean age: 58.1±1.3 years; range, 39 to 81 years) who underwent pleurectomy-decortication and hyperthermic intrathoracic chemotherapy with the diagnosis of malignant pleural mesothelioma were retrospectively analyzed. Data including characteristics, comorbidities, postoperative complications, recurrence and mortality status of the patients were recorded. Overall survival and disease-free survival and prognostic factors were evaluated.

RESULTS

The median disease-free survival was 11.67 months and the median overall survival was 24.60 months. The median disease-free survival was 8.80 months in men and 13.17 months in women, indicating a statistically significant difference as it showed that recurrence was detected earlier in male patients (p=0.037). The median disease-free survival and overall survival was 6.13 months and 11.70 in cases diagnosed with biphasic mesothelioma, respectively, while it was 11.67 months and 25.46 months in cases with epithelial mesothelioma, respectively. Pathological subtype was found to be an effective prognostic factor for both survival (p=0.049 and p<0.001, respectively).

CONCLUSION

Hyperthermic intrathoracic chemotherapy following cytoreductive surgery is a preferable and tolerable method in the treatment of malignant pleural mesothelioma. While evaluating surgical indications, it should be kept in mind that cases with epithelial mesothelioma may benefit more from surgical treatment.

Для цитирования: Ergönül Ayşe Gül, Aydın Sercan, Kahraman Aydın Seda, Akçam Tevfik İlker, Özdil Ali, Turhan Kutsal, Çakan Alpaslan, Çağırıcı Ufuk. Survival of pleurectomy-decortication and hyperthermic chemotherapy in mesothelioma.. Turk gogus kalp damar cerrahisi dergisi. 2023. DOI: 10.5606/tgkdc.dergisi.2023.24329.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.